molecular entity


Also found in: Wikipedia.

molecular entity

[mə′lek·yə·lər ′en·təd·ē]
(chemistry)
A chemically or isotopically distinct atom, molecule, ion, complex, free radical, or similar unit that can be distinguished from other kinds of units.
References in periodicals archive ?
a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it had a pre-investigational new drug (pre-IND) meeting with the U.
They, along with efficacy, are critical properties in determining whether a new molecular entity will become a clinical candidate and subsequently, another drug on the market.
A phybrid is a peptide hybrid molecule that combines the pharmacological effects of two peptide hormones into a single molecular entity.
Abbott (NYSE: ABT) reported today that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
Tekturna, a new molecular entity (NME), is the first high blood pressure drug approved by FDA that inhibits renin, a kidney enzyme associated with the regulation of blood pressure.
At the same time, the new molecular entity is considered to have fewer deleterious peripheral side effects associated with estrogen-like activity.
It also reflects how Montaigne seems to touch and feel his environing world as a molecular entity, the knowledge of whose variety and life supersedes ideologies all the while one can grant them their passing privilege.
NU100 is a proprietary recombinant human interferon beta-1b (IFN beta-1b) being developed as a new molecular entity.
a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application titled, "Methylphenidate-oxoacid conjugates, processes of making and using the same.
Tyzeka is a new molecular entity, which is a term used by the FDA to describe a medication containing an active substance that has never before been approved for marketing in any form in the United States.
Tapentadol Would be the First New Molecular Entity in the Class of Oral Centrally Acting Analgesics to Enter Medical Practice in Over 25 Years
Phase I studies are mainly conducted to generate information about the toxicity of a New Molecular Entity (NME).

Full browser ?